Role of folic Acid on symptoms of chronic arsenic toxicity
Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are fou...
Saved in:
Published in: | International journal of preventive medicine Vol. 5; no. 1; pp. 89 - 98 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Iran
Medknow Publications & Media Pvt Ltd
01-01-2014
Wolters Kluwer Medknow Publications |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are found to have at greater risk of developing symptoms of arsenicosis including its complications. The biochemical pathway responsible for methylation of arsenic is a folate-dependent pathway. Studies in rodents and humans suggest that folate nutritional status influences the metabolism of arsenic.
The present study compares the effect of giving folic acid on 32 arsenicosis patients during a 6-month period and comparing the results with clinical effect of taking only arsenic-free safe water on 45 age and sex-matched arsenic-affected people for the same period.
There was significant improvement of arsenical skin lesion score of both patients treated with folic acid (2.96 ± 1.46 to 1.90 ± 0.90, P < 0.001) and arsenic free safe water (2.91 ± 1.26 to 1.62 ± 1.05, P < 0.001) for a period of 6 months. Significant improvement in systemic disease score was also observed from the baseline systemic score in folic acid treated group (4.78 ± 3.43 to 1.00 ± 1.56, P < 0.001) and the group treated with arsenic-free water (1.87 ± 2.11 to 0.82 ± 1.62, P < 0.001). However, there was a significant increased improvement of systematic disease score in the folic acid treated group compared to the control group taking arsenic free water (P < 0.001).
This study provides evidence that folic acid treatment in arsenicosis cases could help in reducing clinical symptoms of arsenicosis. |
---|---|
AbstractList | BACKGROUNDChronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are found to have at greater risk of developing symptoms of arsenicosis including its complications. The biochemical pathway responsible for methylation of arsenic is a folate-dependent pathway. Studies in rodents and humans suggest that folate nutritional status influences the metabolism of arsenic. METHODSThe present study compares the effect of giving folic acid on 32 arsenicosis patients during a 6-month period and comparing the results with clinical effect of taking only arsenic-free safe water on 45 age and sex-matched arsenic-affected people for the same period. RESULTSThere was significant improvement of arsenical skin lesion score of both patients treated with folic acid (2.96 ± 1.46 to 1.90 ± 0.90, P < 0.001) and arsenic free safe water (2.91 ± 1.26 to 1.62 ± 1.05, P < 0.001) for a period of 6 months. Significant improvement in systemic disease score was also observed from the baseline systemic score in folic acid treated group (4.78 ± 3.43 to 1.00 ± 1.56, P < 0.001) and the group treated with arsenic-free water (1.87 ± 2.11 to 0.82 ± 1.62, P < 0.001). However, there was a significant increased improvement of systematic disease score in the folic acid treated group compared to the control group taking arsenic free water (P < 0.001). CONCLUSIONSThis study provides evidence that folic acid treatment in arsenicosis cases could help in reducing clinical symptoms of arsenicosis. Background: Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are found to have at greater risk of developing symptoms of arsenicosis including its complications. The biochemical pathway responsible for methylation of arsenic is a folate-dependent pathway. Studies in rodents and humans suggest that folate nutritional status influences the metabolism of arsenic. Methods: The present study compares the effect of giving folic acid on 32 arsenicosis patients during a 6-month period and comparing the results with clinical effect of taking only arsenic-free safe water on 45 age and sex-matched arsenic-affected people for the same period. Results: There was significant improvement of arsenical skin lesion score of both patients treated with folic acid (2.96 ± 1.46 to 1.90 ± 0.90, P < 0.001) and arsenic free safe water (2.91 ± 1.26 to 1.62 ± 1.05, P < 0.001) for a period of 6 months. Significant improvement in systemic disease score was also observed from the baseline systemic score in folic acid treated group (4.78 ± 3.43 to 1.00 ± 1.56, P < 0.001) and the group treated with arsenic-free water (1.87 ± 2.11 to 0.82 ± 1.62, P < 0.001).However, there was a significant increased improvement of systematic disease score in the folic acid treated group compared to the control group taking arsenic free water ( P < 0.001). Conclusions: This study provides evidence that folic acid treatment in arsenicosis cases could help in reducing clinical symptoms of arsenicosis. Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are found to have at greater risk of developing symptoms of arsenicosis including its complications. The biochemical pathway responsible for methylation of arsenic is a folate-dependent pathway. Studies in rodents and humans suggest that folate nutritional status influences the metabolism of arsenic. The present study compares the effect of giving folic acid on 32 arsenicosis patients during a 6-month period and comparing the results with clinical effect of taking only arsenic-free safe water on 45 age and sex-matched arsenic-affected people for the same period. There was significant improvement of arsenical skin lesion score of both patients treated with folic acid (2.96 ± 1.46 to 1.90 ± 0.90, P < 0.001) and arsenic free safe water (2.91 ± 1.26 to 1.62 ± 1.05, P < 0.001) for a period of 6 months. Significant improvement in systemic disease score was also observed from the baseline systemic score in folic acid treated group (4.78 ± 3.43 to 1.00 ± 1.56, P < 0.001) and the group treated with arsenic-free water (1.87 ± 2.11 to 0.82 ± 1.62, P < 0.001). However, there was a significant increased improvement of systematic disease score in the folic acid treated group compared to the control group taking arsenic free water (P < 0.001). This study provides evidence that folic acid treatment in arsenicosis cases could help in reducing clinical symptoms of arsenicosis. |
Author | Majumdar, Kunal Kanti Saha, C K Mazumder, D N Guha Ghose, Nelima Nandy, A K Ghose, A K |
AuthorAffiliation | 2 Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India 1 Department of Community Medicine, KPC Medical College and Hospital, Jadavpur, Kolkata, India DNGM Research Foundation, Kolkata, India 3 Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India |
AuthorAffiliation_xml | – name: DNGM Research Foundation, Kolkata, India – name: 2 Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India – name: 3 Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India – name: 1 Department of Community Medicine, KPC Medical College and Hospital, Jadavpur, Kolkata, India |
Author_xml | – sequence: 1 givenname: Nelima surname: Ghose fullname: Ghose, Nelima organization: DNGM Research Foundation, Kolkata, India – sequence: 2 givenname: Kunal Kanti surname: Majumdar fullname: Majumdar, Kunal Kanti organization: Department of Community Medicine, KPC Medical College and Hospital, Jadavpur, Kolkata, India – sequence: 3 givenname: A K surname: Ghose fullname: Ghose, A K organization: DNGM Research Foundation, Kolkata, India – sequence: 4 givenname: C K surname: Saha fullname: Saha, C K organization: Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India – sequence: 5 givenname: A K surname: Nandy fullname: Nandy, A K organization: Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India – sequence: 6 givenname: D N Guha surname: Mazumder fullname: Mazumder, D N Guha organization: DNGM Research Foundation, Kolkata, India |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24554997$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkFtLAzEQhYNUbK39C7KPvhRy3U18EErxUhAE0eeQTWbblN1N3WzF_ntTW8VmHs4wZ-Y7kEs0aEMLZ2hEMZZTSQkbHPtCYjpEkxjXOD2m8pyKCzSkXAiuVDFCt6-hhixUWRVqb7OZ9S4LbRZ3zaYPTdw7dtWFNnmmi7DXPnx56_vdFTqvTB1hctQxen-4f5s_TZ9fHhfz2fPUMUb7acVymsoorDgT1AGWtjQcO0GIFYxIDoSAkkzmsiDMMFcZ4IRj5UogwNgYLQ5cF8xabzrfmG6ng_H6ZxC6pTZd720N2hpl0lHuaEm4TZmlKHIsSVJgBkxi3R1Ym23ZgLPQ9p2pT6CnTutXehk-NVNE8EIlwM0R0IWPLcReNz5aqGvTQthGTQQmrOBEFGn1-n_WX8jv57NvRK6DYg |
ContentType | Journal Article |
Copyright | Copyright: © International Journal of Preventive Medicine 2014 |
Copyright_xml | – notice: Copyright: © International Journal of Preventive Medicine 2014 |
DBID | NPM 7X8 5PM DOA |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 2008-8213 |
EndPage | 98 |
ExternalDocumentID | oai_doaj_org_article_ca9abe16d2b14c6a9b5760819b5e3aea 24554997 |
Genre | Journal Article |
GroupedDBID | --- 3V. 53G 5VS 7X7 7XC 8FE 8FH 8FI 8FJ 8G5 AAKDD ABDBF ABUWG ABXLX ACGFS ADBBV ADRAZ AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CWDGH DIK DWQXO EBD EOJEC ESX FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IEA IHR IHW IPNFZ ITC KQ8 KWQ M2O M48 M~E NPM O5R O5S OBODZ OK1 OVD P2P PGMZT PIMPY PQQKQ PROAC RIG RMW RNS RPM TEORI TUS UKHRP W3E 7X8 5PM |
ID | FETCH-LOGICAL-d332t-f362626a9094352de08cba40d511c53184e11e983868713a3dfae41409dbe1e33 |
IEDL.DBID | RPM |
ISSN | 2008-7802 |
IngestDate | Tue Oct 22 15:08:49 EDT 2024 Tue Sep 17 20:35:51 EDT 2024 Sat Aug 17 03:56:20 EDT 2024 Sat Sep 28 08:01:56 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Arsenicosis treatment of arsenicosis nutritional deficiency folic acid |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-d332t-f362626a9094352de08cba40d511c53184e11e983868713a3dfae41409dbe1e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915479/ |
PMID | 24554997 |
PQID | 1501374157 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ca9abe16d2b14c6a9b5760819b5e3aea pubmedcentral_primary_oai_pubmedcentral_nih_gov_3915479 proquest_miscellaneous_1501374157 pubmed_primary_24554997 |
PublicationCentury | 2000 |
PublicationDate | 2014-Jan 20140101 2014-01-01 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-Jan |
PublicationDecade | 2010 |
PublicationPlace | Iran |
PublicationPlace_xml | – name: Iran – name: India |
PublicationTitle | International journal of preventive medicine |
PublicationTitleAlternate | Int J Prev Med |
PublicationYear | 2014 |
Publisher | Medknow Publications & Media Pvt Ltd Wolters Kluwer Medknow Publications |
Publisher_xml | – name: Medknow Publications & Media Pvt Ltd – name: Wolters Kluwer Medknow Publications |
References | 6894292 - Int Arch Occup Environ Health. 1981;48(1):71-9 10536752 - Drug Chem Toxicol. 1999 Nov;22(4):613-28 15238285 - Environ Health Perspect. 2004 Jul;112(10):1104-9 18709164 - Environ Health Perspect. 2008 Aug;116(8):1056-62 15694460 - Toxicol Appl Pharmacol. 2005 Feb 15;203(1):18-26 11778664 - J Toxicol Clin Toxicol. 2001;39(7):665-74 15941889 - Am J Clin Nutr. 2005 Jun;81(6):1372-7 3590229 - Toxicol Lett. 1987 Jun;37(1):41-6 20922118 - Indian J Community Med. 2010 Apr;35(2):331-8 14581169 - Toxicol Lett. 2003 Nov 30;145(2):167-74 9219569 - Mutat Res. 1997 Jun;386(3):315-34 11484904 - Pharmacol Toxicol. 2001 Jul;89(1):1-5 12635824 - J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003 Jan;38(1):141-63 17093162 - Am J Clin Nutr. 2006 Nov;84(5):1093-101 10884384 - J Biol Chem. 2000 Sep 22;275(38):29318-23 12846360 - Cancer Causes Control. 2003 May;14(4):303-10 8793350 - Environ Health Perspect. 1996 Jun;104(6):620-8 9865236 - J Toxicol Clin Toxicol. 1998;36(7):683-90 16039941 - Toxicol Appl Pharmacol. 2005 Aug 15;206(3):299-308 11097236 - Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1259-62 10397578 - Int J Dermatol. 1999 Jun;38(6):401-10 16330347 - Environ Health Perspect. 2005 Dec;113(12):1683-8 12176088 - Food Chem Toxicol. 2002 Nov;40(11):1611-21 12661181 - J Occup Environ Med. 2003 Mar;45(3):241-8 9264271 - Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):589-96 |
References_xml | |
SSID | ssj0000396625 |
Score | 2.056211 |
Snippet | Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory.... BACKGROUNDChronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is... Background: Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is... |
SourceID | doaj pubmedcentral proquest pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 89 |
SubjectTerms | Arsenicosis folic acid nutritional deficiency Original treatment of arsenicosis |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA66J0HEt-uLCF6LbZK2qTcfu3jy4AO8lTSZ4oLbLrYL-u-dadZlVwQvngqdQ6czaeebyeQbxs51LGIpIhdEVrlAORUHBqNUECLWsDpM01B0Q2wf0_sXfTsgmpz5qC_qCfP0wN5wF9ZkpoAocaKIlE1MViBCpjhWxCANeGgUJgvJVPcPlgjju4mr3f5-qqls0pHy_4YkfzZELkSY4SbbmEFDfuVV2mIrUG2zdV9X4_640A67fKjfgNclL4nQlxs7cryuePM5nrT1uCGJ9Xy3HFNWoGtbf4wsgu1d9jwcPN3cBbP5B4GTUrRBSVQxAl-Zuv9i4SDUtjAqdAiSLH47WkEUQaalTjDtkUa60oAiBiuHFgMp91ivqis4YFwlxpUxjT9wQoGl07CqUCYrAQQNQ--zazJOPvEUFzmRTnc30BX5zBX5X67os7Nv0-a4SGnnwVRQT5scUWckCbukfbbvTT1_lFAx5agoSZecsKTLsqQavXZE2ERur9Ls8D-UP2JriIWUr64cs177PoUTttq46Wm3tL4AP4vVVw priority: 102 providerName: Directory of Open Access Journals |
Title | Role of folic Acid on symptoms of chronic arsenic toxicity |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24554997 https://search.proquest.com/docview/1501374157 https://pubmed.ncbi.nlm.nih.gov/PMC3915479 https://doaj.org/article/ca9abe16d2b14c6a9b5760819b5e3aea |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5sT4KIb-uLCF7TJrubJvFWa4sXRWwFb2GzO9FCm5Q-QP-9O5tUWvHkKZAlm2Fmkv1md-YbgJsoYAFnvnZ9JbQrtAhcaVYp1zNYQ0VeGHrMNrEdhE9v0X2PaHKCVS2MTdpX6aiZjyfNfPRhcyunE9Va5Ym1nh-7RGouwrhVg5rBhmshuv39coPgbbNVe7QfRh51rGEioEgorKj5_8KTv9Mi19aZ_h7sVgDR6ZSC7MMW5gewU-6uOWXR0CHcvhRjdIrM6ROtr9NRI-0UuTP4mkwXxWROIxXrrZlojnQdFp8jZSD3Ebz2e8Pug1t1QXA152zhZkQYw9oyphzAgGn0IpVK4WkDlZT5giKBvo9xxKO2CX645DqTKIjHSqfoI-fHUM-LHE_BEW2ps4CaIGgmUFFNrEiFjDNERi3RG3BHykmmJdFFQtTT9kYxe08qAyRKxtJM3NYs9YUycqUmZCFgkQbIJcoGXK9UmxhXpfMHmWOxnCcGe_qcEEzYgJNS1T-vWtmnAeGGETZk2Rwx3mHpsCtvOPv3k-ewbWCQKDdWLqC-mC3xEmpzvbyyIfqVdbBvxxjU_Q |
link.rule.ids | 230,315,729,782,786,887,2106,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZ4HEBCvB_jWSSuZW2Sri23MZhAPIRgSNyqNHFh0tZObJPg3xOnHWKIE6dKtZJacdJ8TuzPACdRwALOfO36SmhXaBG40uxSrmewhoq8MPSYLWL7FN6_RBeXRJMTTHJhbNC-Srunea9_mnffbGzloK_qkzix-sNdi0jNRRjXZ2HerFfP--Gk2x8wNxjellu1l_th5FHNGiYC8oXCipz_L0T5OzDyx07TXvmnjquwXEFLp1mK12AG83VYKs_lnDLdaAPOHoseOkXmtIkQ2GmqrnaK3Hn67A9GRX9Ikoov13Q0RHp2io-uMmB9E57bl53WlVvVT3A152zkZkQ1wxoypujBgGn0IpVK4WkDspRZe5FA38c44lHDuE1ccp1JFMSApVP0kfMtmMuLHHfAEQ2ps4DKJ2gmUFE2rUiFjDNERsXUa3BOg5oMSoqMhEir7Yvi_TWphiVRMpam44ZmqS-U0Ss1zg5BkjRALlHW4HhiksRMcrq5kDkW42FiUKvPCfuENdguTfT9qYldaxBOGW9Kl2mJsZkl0q5stPvvlkewcNW5u01ur-9v9mDRgClRHs_sw9zofYwHMDvU40M7Pb8A0Nvplg |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fT9swED4NJk1ICDZ-jALbgsRraGI7TcJbKVSbBggNkHiLHPvCKrVJRVuJ_fe7c1JEEU_wFCn-EcufHX9nn78DOEwiEUkRWj80yvrKqsjXtEr5AXENkwRxHAgXxPY6vrxLTs9YJucp1Jdz2jf54Kgcjo7KwV_nWzkemfbcT6x9ddFjUXMVp-2xLdpL8JHmbCCeGeruJyyJx7uQq-6AP6YcrPurIraH4kag_zVW-dI58tlq019_Rzs_w1pDMb1uneULfMByA1br_Tmvvna0Ccd_qiF6VeH1WRjY65qB9arSu_43Gk-r0YRTGt1cqmiC_LypHgeGSPsW3PbPbno__SaOgm-lFFO_YMkZ0dEpexFGwmKQmFyrwBLZMjQHE4VhiGkikw6ZT1JLW2hUrIRlcwxRym1YLqsSd8BTHW2LiMMoWKHQ8K1alSudFoiCg6q34IQ7NhvXUhkZi1e7F9XDfdZ0TWZ0qqnijhV5qAy1Kyejh6lJHqHUqFtwMIclo8HOJxi6xGo2yYi9hpI5UNyCrzVMT5-aY9uCeAHAhbYsphBuTlC7wWn3zSV_wKer0352_uvy9x6sEKdS9S7NPixPH2b4DZYmdvbdjdD_PevsFg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+folic+Acid+on+symptoms+of+chronic+arsenic+toxicity&rft.jtitle=International+journal+of+preventive+medicine&rft.au=Ghose%2C+Nelima&rft.au=Majumdar%2C+Kunal+Kanti&rft.au=Ghose%2C+A+K&rft.au=Saha%2C+C+K&rft.date=2014-01-01&rft.issn=2008-7802&rft.volume=5&rft.issue=1&rft.spage=89&rft.epage=98&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2008-7802&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2008-7802&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2008-7802&client=summon |